#USA #Houston #TR-FRET #Sino Biological #SwiftFluo

Sino Biological's Innovative SwiftFluo® TR-FRET Kits: A New Era in Kinase Screening

Sino Biological, Inc. is excited to announce the launch of its groundbreaking SwiftFluo® TR-FRET kinase assay kits. These kits represent a state-of-the-art, ready-to-use solution that can significantly enhance the detection of kinase activity while efficiently screening for kinase inhibitors. By leveraging advanced Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) technology, these kits offer extraordinary sensitivity, minimal background noise, and robust reproducibility, all essentials for modern scientific research.

Enhanced Performance

The SwiftFluo® TR-FRET kits are meticulously designed to enable swift and reliable high-throughput screening of kinase inhibitors, showcasing advantages over traditional techniques such as radioactive assays, ELISA, and fluorescence intensity-based methods. With these kits, researchers can expect expedited results without compromising accuracy.

Specifically optimized for profiling more than 60 tyrosine kinases (TK), 150 serine/threonine kinases (STK), and 15 cyclin-dependent kinases (CDK), the SwiftFluo® TR-FRET kits ensure comprehensive coverage of critical signaling pathways. Such breadth makes them invaluable tools for researchers exploring kinase functions and their implications in various biological processes.

Apart from the kits themselves, Sino Biological also provides related substrates and corresponding biologically active kinases as stand-alone products. This assortment allows scientists to design custom assays tailored to their unique research needs, thereby maximizing research flexibility.

Streamlined Workflows

Dr. Rob Burgess, the Commercial Director of Sino Biological US, Inc., noted, "Researchers can perform homogeneous, no-wash assays in an easy add-and-read format compatible with standard HTS platforms, eliminating the assay development time and streamlining workflow processes."

This compatibility with high-throughput screening technologies aligns perfectly with the pressure on researchers to deliver results more efficiently, marking a critical advancement in biotechnological research methodologies.

A Commitment to Innovation

In the words of Dr. Jie Zhang, the General Manager at Sino Biological, "We are thrilled to introduce the SwiftFluo® TR-FRET kits as a powerful tool for the global research community. These kits have been designed to balance user-friendliness, cost-effectiveness, and data reproducibility, which are essential conditions for successful high-throughput screening campaigns."

The SwiftFluo® TR-FRET kits enable researchers to transcend traditional limitations and accelerate the pace of drug discovery focused on kinase-targeted therapies. For detailed technical specifications and to witness how the SwiftFluo® TR-FRET kits can propel kinase research, interested parties can visit Sino Biological's website or download the technical Q&A brochure available online.

About Sino Biological

Founded in 2007, Sino Biological is a premier international biotechnology company renowned for its high-quality recombinant proteins, antibodies, and contract research services. Serving researchers across over 90 countries, the company contributes to fundamental research, drug discovery, vaccine development, and diagnostics through its comprehensive product portfolio, exclusive quality systems, and innovative research platforms.

Forward-Looking Statements

This article contains forward-looking statements as per the Private Securities Litigation Reform Act. These statements represent the current expectations of Sino Biological's management and are subject to uncertainties and changes in circumstances. Actual results may differ materially due to a variety of factors beyond Sino Biological's control. The company has no obligation to update these forward-looking statements and does not intend to do so.

For inquiries or partnership opportunities, please contact Sino Biological, Inc. at [email protected]